Exposure to bisphosphonates and risk of gastrointestinal cancers: series of nested case-control studies with QResearch and CPRD data.
about
Oral bisphosphonates and colon cancer: an updateBisphosphonates and evidence for association with esophageal and gastric cancer: a systematic review and meta-analysis.The carcinogenicity of alendronate in patients with osteoporosis: evidence from cohort studiesCardiovascular and neuropsychiatric risks of varenicline: a retrospective cohort studyCan analyses of electronic patient records be independently and externally validated? The effect of statins on the mortality of patients with ischaemic heart disease: a cohort study with nested case-control analysisExposure to sodium channel-inhibiting drugs and cancer survival: protocol for a cohort study using the QResearch primary care databaseOral Bisphosphonates and Upper Gastrointestinal Cancer Risks in Asians with Osteoporosis: A Nested Case-Control Study Using National Retrospective Cohort Sample Data from KoreaSerum creatinine elevation after renin-angiotensin system blockade and long term cardiorenal risks: cohort study.ClinicalCodes: an online clinical codes repository to improve the validity and reproducibility of research using electronic medical records.Cardiovascular and neuropsychiatric safety of varenicline and bupropion compared with nicotine replacement therapy for smoking cessation: study protocol of a retrospective cohort study using the QResearch general practice database.Can analyses of electronic patient records be independently and externally validated? Study 2--the effect of β-adrenoceptor blocker therapy on cancer survival: a retrospective cohort study.Oral Bisphosphonate and Risk of Esophageal Cancer: A Nationwide Claim Study.Oral bisphosphonates and upper gastrointestinal toxicity: a study of cancer and early signals of esophageal injuryOral Bisphosphonate Exposure and the Risk of Upper Gastrointestinal Cancers.Sodium channel-inhibiting drugs and survival of breast, colon and prostate cancer: a population-based studyBisphosphonates as potential adjuvants for patients with cancers of the digestive system.Diabetes treatments and risk of amputation, blindness, severe kidney failure, hyperglycaemia, and hypoglycaemia: open cohort study in primary careDiabetes treatments and risk of heart failure, cardiovascular disease, and all cause mortality: cohort study in primary careOral bisphosphonates and colorectal cancer.Exposure to combined oral contraceptives and risk of venous thromboembolism: a protocol for nested case-control studies using the QResearch and the CPRD databasesSafety concerns with the long-term management of osteoporosis.Interaction of XRCC1 Arg399Gln Polymorphism and Alcohol Consumption Influences Susceptibility of Esophageal Cancer.Efficacy, effectiveness and side effects of medications used to prevent fractures.Pioglitazone and bladder cancer: two studies, same database, two answersOral bisphosphonate use and age-related macular degeneration: retrospective cohort and nested case-control study.Clinical impact of bisphosphonates in root canal therapy.Prognostic Effect of Bisphosphonate Exposure for Patients With Diagnosed Solid Cancer: A Systematic Review With Meta-Analysis of Observational Studies
P2860
Q26796479-C5B50D0F-45E1-4E09-89DA-A317BBA07F8AQ27693291-DBAE1CC6-237F-4A11-B2C7-06BECAAA7182Q28087279-8D437FE5-8ABE-42F2-87A5-F53E8900BED9Q28267175-3C83ACBB-EF18-4091-9E32-AAAF23EE8775Q28385268-B8944BE4-3500-4AE8-BE57-5348D4339974Q28651415-EE5F62CB-6ED0-48FD-A2B1-9D208BE5E0F8Q31052317-1CD9237E-8AD0-42D4-BD7F-A786EBB8A2BEQ33647372-2801EDEA-A8B5-4603-A6BA-6F33FC55E4C6Q33773882-3E4D7D15-BFB6-44AE-8A19-DC27EE8E0DF0Q34144971-0C21C09F-A640-42FF-86C2-02FB9F9A7EDDQ35466477-11A7D731-91E7-42FA-A038-475B65AE174BQ35739607-B1D8EDD6-AFF8-4110-804E-10667E7324CFQ35878736-BAD75AFF-0AAF-4ABD-985B-91ABE9823F9DQ36132106-165EDCC1-3919-4CE6-87F5-7F059EBEC900Q36291060-CDFA1A03-AFB0-40B2-A9F3-4F0D1AE1D865Q36471673-3F7EA732-E588-460C-B24B-609C2F48D2C7Q36753481-E197EA07-C744-47D7-AB3B-3F0A1ADC9FB0Q37101613-1E0E1887-3121-4300-8397-ED1CBFF01397Q37692229-202EB146-97DA-4291-9F17-BA65953EAEFCQ37704438-1F94F0B2-E5DB-4F98-AAD6-5E28CEAA04C0Q38101363-7FE4496D-D4DB-4570-885E-54BD3CB4D6F7Q38426462-492B7107-57F0-47AF-8A87-3FC964C352EEQ41704607-41FE2209-B0E2-4722-A483-8E91BE7D5037Q41825937-70571253-F671-4E97-BB90-3875A2179460Q49831235-42FB0E37-09FA-4A60-AD7C-5245CF43A519Q55032991-B8147F65-A290-4F75-B0E3-4704B76D2B1AQ58694969-10F8FAA5-F83A-4D52-93BC-DE59393DCF12
P2860
Exposure to bisphosphonates and risk of gastrointestinal cancers: series of nested case-control studies with QResearch and CPRD data.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Exposure to bisphosphonates an ...... with QResearch and CPRD data.
@ast
Exposure to bisphosphonates an ...... with QResearch and CPRD data.
@en
Exposure to bisphosphonates an ...... with QResearch and CPRD data.
@nl
type
label
Exposure to bisphosphonates an ...... with QResearch and CPRD data.
@ast
Exposure to bisphosphonates an ...... with QResearch and CPRD data.
@en
Exposure to bisphosphonates an ...... with QResearch and CPRD data.
@nl
prefLabel
Exposure to bisphosphonates an ...... with QResearch and CPRD data.
@ast
Exposure to bisphosphonates an ...... with QResearch and CPRD data.
@en
Exposure to bisphosphonates an ...... with QResearch and CPRD data.
@nl
P2860
P356
P1433
P1476
Exposure to bisphosphonates an ...... with QResearch and CPRD data.
@en
P2093
Yana Vinogradova
P2860
P356
10.1136/BMJ.F114
P407
P577
2013-01-16T00:00:00Z